Evidence map›Paper›PMID 42290190›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2026

DNA-Enzyme Hybrid Nanostructures: Functional Materials to Modulate Enzymatic Activity.

Manar Elnaggar, Amelie Heuer-Jungemann

Abstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Manar ElnaggarMax Planck Institute of Biochemistry, Center for Nanoscience, LMU, Munich, Germany.
Amelie Heuer-JungemannMax Planck Institute of Biochemistry, Center for Nanoscience, LMU, Munich, Germany.ORCID 0000-0003-3630-6389

Funding

Deutsche Forschungsgemeinschaft (DFG)Emmy Noether program 427981116
6 · The paper itself

Abstract

DNA nanotechnology enables the precise assembly of complex and versatile 2-dimensional (2D) and 3-dimensional (3D) nanostructures. Coupling enzymes to such DNA nanostructures offers great control over the enzymes' positioning and stoichiometry to modify their activity and unleash their maximum catalytic capacity. While enzymes hosted on DNA nanostructures have shown predominantly enhanced enzymatic activity, existing hypotheses such as proximity effects, electrostatic interactions, and pH modulation fail to fully account for the observed enhancement. Protection against enzymatic deactivation plays a role, but additional mechanisms, including potential hydration layer stabilization, require further investigation. Furthermore, spatial proximity alone does not guarantee efficiency in multi-enzyme cascades, particularly in systems with unbalanced kinetics. Another big challenge remains when it comes to addressing disproportionally large enzymes. In this review, we summarize recent literature on DNA-enzyme hybrid nanostructures and critically discuss the proposed hypotheses, aiming to shed light on the change in enzymatic activity upon conjugation to DNA nanostructures. We highlight gaps and remaining open questions in the field as well as giving a brief overview of potential applications of such DNA-enzyme hybrid nanostructures.

Indexed as

DNAEnzymesNanostructuresBiocatalysisDNA NanostructuresNanotechnologyDNAEnzymesbiocatalysisDNA‐enzyme hybrid nanostructuresDNA origamienzymes

Identifiers

PMID42290190
PMCPMC13432680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.